{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T14:50:05Z","timestamp":1776783005771,"version":"3.51.2"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009066","name":"Carlos Slim Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009066","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista de Investigaci\u00f3n Cl\u00ednica"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ric.2026.100038","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T16:21:51Z","timestamp":1774023711000},"page":"100038","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and validation of a predictive model for the lifetime risk of end-stage kidney disease in autosomal dominant polycystic kidney disease"],"prefix":"10.1016","volume":"78","author":[{"given":"Juan Jos\u00e9","family":"Aguilar-Lugo-Gerez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2189-6523","authenticated-orcid":false,"given":"Pamela","family":"Rivero-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2436-9406","authenticated-orcid":false,"given":"Diego Luis","family":"Carrillo-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Correa-Rotter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9569","key":"10.1016\/j.ric.2026.100038_bib0135","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","article-title":"Autosomal dominant polycystic kidney disease","volume":"369","author":"Torres","year":"2007","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ric.2026.100038_bib0140","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ki.2015.59","article-title":"Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"88","author":"Chapman","year":"2015","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.ric.2026.100038_bib0145","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/ki.1983.51","article-title":"Rate of functional deterioration in polycystic kidney disease","volume":"23","author":"Franz","year":"1983","journal-title":"Kidney Int"},{"issue":"14","key":"10.1016\/j.ric.2026.100038_bib0150","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMcp0804458","article-title":"Clinical practice. Autosomal dominant polycystic kidney disease","volume":"359","author":"Grantham","year":"2008","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.ric.2026.100038_bib0155","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1056\/NEJMoa054341","article-title":"Volume progression in polycystic kidney disease","volume":"354","author":"Grantham","year":"2006","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ric.2026.100038_bib0160","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1681\/ASN.2013101138","article-title":"Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials","volume":"2","author":"Irazabal","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"25","key":"10.1016\/j.ric.2026.100038_bib0165","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"367","author":"Torres","year":"2012","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ric.2026.100038_bib0170","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/ndt\/gfv456","article-title":"Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice","volume":"31","author":"Gansevoort","year":"2016","journal-title":"Nephrol Dial Transplant"},{"issue":"20","key":"10.1016\/j.ric.2026.100038_bib0175","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1056\/NEJMoa1710030","article-title":"Tolvaptan in later-stage autosomal dominant polycystic kidney disease","volume":"377","author":"Torres","year":"2017","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ric.2026.100038_bib0180","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1159\/000045214","article-title":"Prevalence and renal prognosis of diagnosed autosomal dominant polycystic kidney disease in Japan","volume":"80","author":"Higashihara","year":"1998","journal-title":"Nephron"},{"issue":"1","key":"10.1016\/j.ric.2026.100038_bib0185","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1681\/ASN.2008050507","article-title":"Unified criteria for ultrasonographic diagnosis of ADPKD","volume":"20","author":"Pei","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.ric.2026.100038_bib0190","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1681\/ASN.2014030297","article-title":"Imaging-based diagnosis of autosomal dominant polycystic kidney disease","volume":"26","author":"Pei","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"19","key":"10.1016\/j.ric.2026.100038_bib0195","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"issue":"10258","key":"10.1016\/j.ric.2026.100038_bib0200","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0140-6736(20)30677-2","article-title":"Fertility, mortality, migration, and population scenarios for 195 countries and territories from 2017 to 2100: a forecasting analysis for the Global Burden of Disease Study","volume":"396","author":"Vollset","year":"2020","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ric.2026.100038_bib0205","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/ndt\/gfw237","article-title":"Clinical associations of total kidney volume: the Framingham Heart Study","volume":"32","author":"Roseman","year":"2017","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.ric.2026.100038_bib0210","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2215\/CJN.00080605","article-title":"Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort","volume":"1","author":"Bae","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.ric.2026.100038_bib0215","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1007\/s00701-017-3316-8","article-title":"Relationship between intracranial aneurysms and the severity of autosomal dominant polycystic kidney disease","volume":"159","author":"Yoshida","year":"2017","journal-title":"Acta Neurochir (Wien)"},{"issue":"2","key":"10.1016\/j.ric.2026.100038_bib0220","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1053\/j.ackd.2010.01.002","article-title":"Molecular advances in autosomal dominant polycystic kidney disease","volume":"17","author":"Gallagher","year":"2010","journal-title":"Adv Chronic Kidney Dis"},{"issue":"2","key":"10.1016\/j.ric.2026.100038_bib0225","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/j.ackd.2009.12.001","article-title":"Diagnosis and screening of autosomal dominant polycystic kidney disease","volume":"17","author":"Pei","year":"2010","journal-title":"Adv Chronic Kidney Dis"},{"issue":"5","key":"10.1016\/j.ric.2026.100038_bib0230","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2215\/CJN.0000000000000427","article-title":"Validation of the Mayo Imaging Classification System for predicting kidney outcomes in ADPKD","volume":"19","author":"Bais","year":"2024","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.ric.2026.100038_bib0235","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1681\/ASN.2007010125","article-title":"Genotype\u2013phenotype correlations in autosomal dominant and autosomal recessive polycystic kidney disease","volume":"18","author":"Rossetti","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.ric.2026.100038_bib0240","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1681\/ASN.2012070650","article-title":"Type of PKD1 mutation influences renal outcome in ADPKD","volume":"24","author":"Cornec-Le Gall","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.ric.2026.100038_bib0245","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1681\/ASN.2015050583","article-title":"Predicted mutation strength of nontruncating PKD1 mutations aids genotype\u2013phenotype correlations in autosomal dominant polycystic kidney disease","volume":"27","author":"Heyer","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.ric.2026.100038_bib0250","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1681\/ASN.2015010016","article-title":"The PROPKD score: a new algorithm to predict renal survival in autosomal dominant polycystic kidney disease","volume":"27","author":"Cornec-Le Gall","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"10058","key":"10.1016\/j.ric.2026.100038_bib0255","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1016\/S0140-6736(16)31773-1","article-title":"Dissonant health transition in the states of Mexico, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"388","author":"Gomez-Dantes","year":"2016","journal-title":"Lancet"},{"issue":"2S","key":"10.1016\/j.ric.2026.100038_bib0260","first-page":"S1","article-title":"KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD)","volume":"107","year":"2025","journal-title":"Kidney Int"}],"container-title":["Revista de Investigaci\u00f3n Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034837626000057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034837626000057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T13:47:51Z","timestamp":1776779271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0034837626000057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0034837626000057"],"URL":"https:\/\/doi.org\/10.1016\/j.ric.2026.100038","relation":{},"ISSN":["0034-8376"],"issn-type":[{"value":"0034-8376","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of a predictive model for the lifetime risk of end-stage kidney disease in autosomal dominant polycystic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Revista de Investigaci\u00f3n Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ric.2026.100038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubiran.","name":"copyright","label":"Copyright"}],"article-number":"100038"}}